# Impact of Atrial Fibrillation Prediction Model on Prescribing Oral Anti-Coagulation in Patients With Cryptogenic Stroke

Study · id `cardio:ct-nct07934511` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07934511](<https://clinicaltrials.gov/study/NCT07934511>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07934511

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT07934511. Allocation not applicable; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2028-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT07934511, source copy `cardio:ctgov-nct07934511-2026-11-13`, retrieved 2026-11-18)
- Planned start: 2026-11 (anticipated) (ClinicalTrials.gov record NCT07934511, source copy `cardio:ctgov-nct07934511-2026-11-13`, retrieved 2026-11-18)
- Primary completion: 2028-09 (anticipated) (ClinicalTrials.gov record NCT07934511, source copy `cardio:ctgov-nct07934511-2026-11-13`, retrieved 2026-11-18)
- Completion: 2028-10 (anticipated) (ClinicalTrials.gov record NCT07934511, source copy `cardio:ctgov-nct07934511-2026-11-13`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT07934511, source copy `cardio:ctgov-nct07934511-2026-11-13`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07934511-2026-11-13`, retrieved 2026-11-18)

## The registry's words

- Brief title: Impact of Atrial Fibrillation Prediction Model on Prescribing Oral Anti-Coagulation in Patients With Cryptogenic Stroke
- Condition: Stroke
- Intervention (Device): UPMC AF Prediction Model
- Lead sponsor: Samir Saba
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 3ba6a75dee12644c373cf6f858d573d760a6d98ce6f9f04f0b155b2025196a74
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
